Report Detail
Global Nanoparticle-Mediated Delivery Market Growth (Status and Outlook) 2022-2028
- RnM4468438 |
- 19 July, 2022 |
- Global |
- 110 Pages |
- LPI(LP Information) |
- Medical Devices & Consumables
As the global economy mends, the 2021 growth of Nanoparticle-Mediated Delivery will have significant change from previous year. According to our (LP Information) latest study, the global Nanoparticle-Mediated Delivery market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Nanoparticle-Mediated Delivery market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Nanoparticle-Mediated Delivery market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Nanoparticle-Mediated Delivery market, reaching US$ million by the year 2028. As for the Europe Nanoparticle-Mediated Delivery landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Nanoparticle-Mediated Delivery players cover AbbVie, BlueWillow Biologics, NovaSOL, and Camurus, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Nanoparticle-Mediated Delivery market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Biological Origin
Non-Biological Origin
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Drug Delivery
Gene Delivery
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
AbbVie
BlueWillow Biologics
NovaSOL
Camurus
Ceramisphere
Celgene, CytImmune
Cristal Therapeutics
EnColl
Lena Nanoceutics Ltd.
EyePoint Pharmaceuticals
Nanobiotix
NanoCarrier
Nanospectra
NanOlogy
Selecta Biosciences
Parvus Therapeutics
Starpharma
Tarveda Therapeutics
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Nanoparticle-Mediated Delivery Market Size 2017-2028
- 2.1.2 Nanoparticle-Mediated Delivery Market Size CAGR by Region 2017 VS 2022 VS 2028
- 2.2 Nanoparticle-Mediated Delivery Segment by Type
- 2.2.1 Biological Origin
- 2.2.2 Non-Biological Origin
- 2.3 Nanoparticle-Mediated Delivery Market Size by Type
- 2.3.1 Nanoparticle-Mediated Delivery Market Size CAGR by Type (2017 VS 2022 VS 2028)
- 2.3.2 Global Nanoparticle-Mediated Delivery Market Size Market Share by Type (2017-2022)
- 2.4 Nanoparticle-Mediated Delivery Segment by Application
- 2.4.1 Drug Delivery
- 2.4.2 Gene Delivery
- 2.5 Nanoparticle-Mediated Delivery Market Size by Application
- 2.5.1 Nanoparticle-Mediated Delivery Market Size CAGR by Application (2017 VS 2022 VS 2028)
- 2.5.2 Global Nanoparticle-Mediated Delivery Market Size Market Share by Application (2017-2022)
3 Nanoparticle-Mediated Delivery Market Size by Player
- 3.1 Nanoparticle-Mediated Delivery Market Size Market Share by Players
- 3.1.1 Global Nanoparticle-Mediated Delivery Revenue by Players (2020-2022)
- 3.1.2 Global Nanoparticle-Mediated Delivery Revenue Market Share by Players (2020-2022)
- 3.2 Global Nanoparticle-Mediated Delivery Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Nanoparticle-Mediated Delivery by Regions
- 4.1 Nanoparticle-Mediated Delivery Market Size by Regions (2017-2022)
- 4.2 Americas Nanoparticle-Mediated Delivery Market Size Growth (2017-2022)
- 4.3 APAC Nanoparticle-Mediated Delivery Market Size Growth (2017-2022)
- 4.4 Europe Nanoparticle-Mediated Delivery Market Size Growth (2017-2022)
- 4.5 Middle East & Africa Nanoparticle-Mediated Delivery Market Size Growth (2017-2022)
5 Americas
- 5.1 Americas Nanoparticle-Mediated Delivery Market Size by Country (2017-2022)
- 5.2 Americas Nanoparticle-Mediated Delivery Market Size by Type (2017-2022)
- 5.3 Americas Nanoparticle-Mediated Delivery Market Size by Application (2017-2022)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Nanoparticle-Mediated Delivery Market Size by Region (2017-2022)
- 6.2 APAC Nanoparticle-Mediated Delivery Market Size by Type (2017-2022)
- 6.3 APAC Nanoparticle-Mediated Delivery Market Size by Application (2017-2022)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Nanoparticle-Mediated Delivery by Country (2017-2022)
- 7.2 Europe Nanoparticle-Mediated Delivery Market Size by Type (2017-2022)
- 7.3 Europe Nanoparticle-Mediated Delivery Market Size by Application (2017-2022)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Nanoparticle-Mediated Delivery by Region (2017-2022)
- 8.2 Middle East & Africa Nanoparticle-Mediated Delivery Market Size by Type (2017-2022)
- 8.3 Middle East & Africa Nanoparticle-Mediated Delivery Market Size by Application (2017-2022)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Nanoparticle-Mediated Delivery Market Forecast
- 10.1 Global Nanoparticle-Mediated Delivery Forecast by Regions (2023-2028)
- 10.1.1 Global Nanoparticle-Mediated Delivery Forecast by Regions (2023-2028)
- 10.1.2 Americas Nanoparticle-Mediated Delivery Forecast
- 10.1.3 APAC Nanoparticle-Mediated Delivery Forecast
- 10.1.4 Europe Nanoparticle-Mediated Delivery Forecast
- 10.1.5 Middle East & Africa Nanoparticle-Mediated Delivery Forecast
- 10.2 Americas Nanoparticle-Mediated Delivery Forecast by Country (2023-2028)
- 10.2.1 United States Nanoparticle-Mediated Delivery Market Forecast
- 10.2.2 Canada Nanoparticle-Mediated Delivery Market Forecast
- 10.2.3 Mexico Nanoparticle-Mediated Delivery Market Forecast
- 10.2.4 Brazil Nanoparticle-Mediated Delivery Market Forecast
- 10.3 APAC Nanoparticle-Mediated Delivery Forecast by Region (2023-2028)
- 10.3.1 China Nanoparticle-Mediated Delivery Market Forecast
- 10.3.2 Japan Nanoparticle-Mediated Delivery Market Forecast
- 10.3.3 Korea Nanoparticle-Mediated Delivery Market Forecast
- 10.3.4 Southeast Asia Nanoparticle-Mediated Delivery Market Forecast
- 10.3.5 India Nanoparticle-Mediated Delivery Market Forecast
- 10.3.6 Australia Nanoparticle-Mediated Delivery Market Forecast
- 10.4 Europe Nanoparticle-Mediated Delivery Forecast by Country (2023-2028)
- 10.4.1 Germany Nanoparticle-Mediated Delivery Market Forecast
- 10.4.2 France Nanoparticle-Mediated Delivery Market Forecast
- 10.4.3 UK Nanoparticle-Mediated Delivery Market Forecast
- 10.4.4 Italy Nanoparticle-Mediated Delivery Market Forecast
- 10.4.5 Russia Nanoparticle-Mediated Delivery Market Forecast
- 10.5 Middle East & Africa Nanoparticle-Mediated Delivery Forecast by Region (2023-2028)
- 10.5.1 Egypt Nanoparticle-Mediated Delivery Market Forecast
- 10.5.2 South Africa Nanoparticle-Mediated Delivery Market Forecast
- 10.5.3 Israel Nanoparticle-Mediated Delivery Market Forecast
- 10.5.4 Turkey Nanoparticle-Mediated Delivery Market Forecast
- 10.5.5 GCC Countries Nanoparticle-Mediated Delivery Market Forecast
- 10.6 Global Nanoparticle-Mediated Delivery Forecast by Type (2023-2028)
- 10.7 Global Nanoparticle-Mediated Delivery Forecast by Application (2023-2028)
11 Key Players Analysis
- 11.1 AbbVie
- 11.1.1 AbbVie Company Information
- 11.1.2 AbbVie Nanoparticle-Mediated Delivery Product Offered
- 11.1.3 AbbVie Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2020-2022)
- 11.1.4 AbbVie Main Business Overview
- 11.1.5 AbbVie Latest Developments
- 11.2 BlueWillow Biologics
- 11.2.1 BlueWillow Biologics Company Information
- 11.2.2 BlueWillow Biologics Nanoparticle-Mediated Delivery Product Offered
- 11.2.3 BlueWillow Biologics Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2020-2022)
- 11.2.4 BlueWillow Biologics Main Business Overview
- 11.2.5 BlueWillow Biologics Latest Developments
- 11.3 NovaSOL
- 11.3.1 NovaSOL Company Information
- 11.3.2 NovaSOL Nanoparticle-Mediated Delivery Product Offered
- 11.3.3 NovaSOL Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2020-2022)
- 11.3.4 NovaSOL Main Business Overview
- 11.3.5 NovaSOL Latest Developments
- 11.4 Camurus
- 11.4.1 Camurus Company Information
- 11.4.2 Camurus Nanoparticle-Mediated Delivery Product Offered
- 11.4.3 Camurus Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2020-2022)
- 11.4.4 Camurus Main Business Overview
- 11.4.5 Camurus Latest Developments
- 11.5 Ceramisphere
- 11.5.1 Ceramisphere Company Information
- 11.5.2 Ceramisphere Nanoparticle-Mediated Delivery Product Offered
- 11.5.3 Ceramisphere Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2020-2022)
- 11.5.4 Ceramisphere Main Business Overview
- 11.5.5 Ceramisphere Latest Developments
- 11.6 Celgene, CytImmune
- 11.6.1 Celgene, CytImmune Company Information
- 11.6.2 Celgene, CytImmune Nanoparticle-Mediated Delivery Product Offered
- 11.6.3 Celgene, CytImmune Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2020-2022)
- 11.6.4 Celgene, CytImmune Main Business Overview
- 11.6.5 Celgene, CytImmune Latest Developments
- 11.7 Cristal Therapeutics
- 11.7.1 Cristal Therapeutics Company Information
- 11.7.2 Cristal Therapeutics Nanoparticle-Mediated Delivery Product Offered
- 11.7.3 Cristal Therapeutics Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2020-2022)
- 11.7.4 Cristal Therapeutics Main Business Overview
- 11.7.5 Cristal Therapeutics Latest Developments
- 11.8 EnColl
- 11.8.1 EnColl Company Information
- 11.8.2 EnColl Nanoparticle-Mediated Delivery Product Offered
- 11.8.3 EnColl Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2020-2022)
- 11.8.4 EnColl Main Business Overview
- 11.8.5 EnColl Latest Developments
- 11.9 Lena Nanoceutics Ltd.
- 11.9.1 Lena Nanoceutics Ltd. Company Information
- 11.9.2 Lena Nanoceutics Ltd. Nanoparticle-Mediated Delivery Product Offered
- 11.9.3 Lena Nanoceutics Ltd. Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2020-2022)
- 11.9.4 Lena Nanoceutics Ltd. Main Business Overview
- 11.9.5 Lena Nanoceutics Ltd. Latest Developments
- 11.10 EyePoint Pharmaceuticals
- 11.10.1 EyePoint Pharmaceuticals Company Information
- 11.10.2 EyePoint Pharmaceuticals Nanoparticle-Mediated Delivery Product Offered
- 11.10.3 EyePoint Pharmaceuticals Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2020-2022)
- 11.10.4 EyePoint Pharmaceuticals Main Business Overview
- 11.10.5 EyePoint Pharmaceuticals Latest Developments
- 11.11 Nanobiotix
- 11.11.1 Nanobiotix Company Information
- 11.11.2 Nanobiotix Nanoparticle-Mediated Delivery Product Offered
- 11.11.3 Nanobiotix Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2020-2022)
- 11.11.4 Nanobiotix Main Business Overview
- 11.11.5 Nanobiotix Latest Developments
- 11.12 NanoCarrier
- 11.12.1 NanoCarrier Company Information
- 11.12.2 NanoCarrier Nanoparticle-Mediated Delivery Product Offered
- 11.12.3 NanoCarrier Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2020-2022)
- 11.12.4 NanoCarrier Main Business Overview
- 11.12.5 NanoCarrier Latest Developments
- 11.13 Nanospectra
- 11.13.1 Nanospectra Company Information
- 11.13.2 Nanospectra Nanoparticle-Mediated Delivery Product Offered
- 11.13.3 Nanospectra Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2020-2022)
- 11.13.4 Nanospectra Main Business Overview
- 11.13.5 Nanospectra Latest Developments
- 11.14 NanOlogy
- 11.14.1 NanOlogy Company Information
- 11.14.2 NanOlogy Nanoparticle-Mediated Delivery Product Offered
- 11.14.3 NanOlogy Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2020-2022)
- 11.14.4 NanOlogy Main Business Overview
- 11.14.5 NanOlogy Latest Developments
- 11.15 Selecta Biosciences
- 11.15.1 Selecta Biosciences Company Information
- 11.15.2 Selecta Biosciences Nanoparticle-Mediated Delivery Product Offered
- 11.15.3 Selecta Biosciences Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2020-2022)
- 11.15.4 Selecta Biosciences Main Business Overview
- 11.15.5 Selecta Biosciences Latest Developments
- 11.16 Parvus Therapeutics
- 11.16.1 Parvus Therapeutics Company Information
- 11.16.2 Parvus Therapeutics Nanoparticle-Mediated Delivery Product Offered
- 11.16.3 Parvus Therapeutics Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2020-2022)
- 11.16.4 Parvus Therapeutics Main Business Overview
- 11.16.5 Parvus Therapeutics Latest Developments
- 11.17 Starpharma
- 11.17.1 Starpharma Company Information
- 11.17.2 Starpharma Nanoparticle-Mediated Delivery Product Offered
- 11.17.3 Starpharma Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2020-2022)
- 11.17.4 Starpharma Main Business Overview
- 11.17.5 Starpharma Latest Developments
- 11.18 Tarveda Therapeutics
- 11.18.1 Tarveda Therapeutics Company Information
- 11.18.2 Tarveda Therapeutics Nanoparticle-Mediated Delivery Product Offered
- 11.18.3 Tarveda Therapeutics Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2020-2022)
- 11.18.4 Tarveda Therapeutics Main Business Overview
- 11.18.5 Tarveda Therapeutics Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Nanoparticle-Mediated Delivery. Industry analysis & Market Report on Nanoparticle-Mediated Delivery is a syndicated market report, published as Global Nanoparticle-Mediated Delivery Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Nanoparticle-Mediated Delivery market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
